Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of droxidopa and droxidopa + carbidopa for fibromyalgia pain
2008-001123-62Phase 2Completed
- Sponsor
- Chelsea Therapeutics International, Ltd.
- Start
- Apr 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of droxidopa in fibromyalgia (FM) (3 arms), sponsored by Chelsea Therapeutics International, Ltd. Primary endpoint: Primary pain improvement. Started Apr 2008; status: completed.
02
Drugs
droxidopa
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2008-001123-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001123-62.